» Articles » PMID: 36630186

Mechanistic Insights into Silica Nanoparticle-allergen Interactions on Antigen Presenting Cell Function in the Context of Allergic Reactions

Abstract

The incorporation of nanomaterials into consumer products has substantially increased in recent years, raising concerns about their safety. The inherent physicochemical properties of nanoparticles allow them to cross epithelial barriers and gain access to immunocompetent cells. Nanoparticles in cosmetic products can potentially interact with environmental allergens, forming a protein corona, and together penetrate through damaged skin. Allergen-nanoparticle interactions may influence the immune response, eventually resulting in an adverse or beneficial outcome in terms of allergic reactivity. This study determines the impact of silica nanoparticle-allergen interactions on allergic sensitization by studying the major molecular mechanisms affecting allergic responses. The major birch pollen allergen Bet v 1 was chosen as a model allergen and the birch pollen extract as a comparator. Key events in immunotoxicity including allergen uptake, processing, presentation, expression of costimulatory molecules and cytokine release were studied in human monocyte-derived dendritic cells. Using an sensitization model, murine Bet v 1-specific IgG and IgE levels were monitored. Upon the interaction of allergens with silica nanoparticles, we observed an enhanced uptake of the allergen by macropinocytosis, improved proteolytic processing, and presentation concomitant with a propensity to increase allergen-specific IgG2a and decrease IgE antibody levels. Together, these events suggest that upon nanoparticle interactions the immune response is biased towards a type 1 inflammatory profile, characterized by the upregulation of T helper 1 (Th1) cells. In conclusion, the interaction of the birch pollen allergen with silica nanoparticles will not worsen allergic sensitization, a state of type 2-inflammation, but rather seems to decrease it by skewing towards a Th1-dominated immune response.

Citing Articles

Instance maps as an organising concept for complex experimental workflows as demonstrated for (nano)material safety research.

Punz B, Brajnik M, Dokler J, Amos J, Johnson L, Reilly K Beilstein J Nanotechnol. 2025; 16:57-77.

PMID: 39877837 PMC: 11773194. DOI: 10.3762/bjnano.16.7.


Application of Nanoparticles for Immunotherapy of Allergic Rhinitis.

Li K, Jin J, Yang Y, Luo X, Wang Y, Xu A Int J Nanomedicine. 2024; 19:12015-12037.

PMID: 39583318 PMC: 11584337. DOI: 10.2147/IJN.S484327.


To stay or not to stay intact as an allergen: the endolysosomal degradation assay used as tool to analyze protein immunogenicity and cell epitopes.

Oztemiz Topcu E, Gadermaier G Front Allergy. 2024; 5:1440360.

PMID: 39071040 PMC: 11272489. DOI: 10.3389/falgy.2024.1440360.


Recovering What Matters: High Protein Recovery after Endotoxin Removal from LPS-Contaminated Formulations Using Novel Anti-Lipid A Antibody Microparticle Conjugates.

Melo C, Fux A, Himly M, Bastus N, Schlahsa L, Siewert C Int J Mol Sci. 2023; 24(18).

PMID: 37762274 PMC: 10531372. DOI: 10.3390/ijms241813971.


Editorial: Exploring impacts of combined exposures to particles and chemicals on immune reactions across living organisms.

Boraschi D, Duschl A, Lynch I, Stoeger T Front Toxicol. 2023; 5:1148374.

PMID: 36950145 PMC: 10026952. DOI: 10.3389/ftox.2023.1148374.

References
1.
Kratzer B, Hofer S, Zabel M, Pickl W . All the small things: How virus-like particles and liposomes modulate allergic immune responses. Eur J Immunol. 2019; 50(1):17-32. PMC: 6973265. DOI: 10.1002/eji.201847810. View

2.
Hammad H, Charbonnier A, Duez C, Jacquet A, Stewart G, Tonnel A . Th2 polarization by Der p 1--pulsed monocyte-derived dendritic cells is due to the allergic status of the donors. Blood. 2001; 98(4):1135-41. DOI: 10.1182/blood.v98.4.1135. View

3.
Aglas L, Gilles S, Bauer R, Huber S, Araujo G, Mueller G . Context matters: T2 polarization resulting from pollen composition and not from protein-intrinsic allergenicity. J Allergy Clin Immunol. 2018; 142(3):984-987.e6. PMC: 6129402. DOI: 10.1016/j.jaci.2018.05.004. View

4.
Gomord V, Stordeur V, Fitchette A, Fixman E, Tropper G, Garnier L . Design, production and immunomodulatory potency of a novel allergen bioparticle. PLoS One. 2020; 15(12):e0242867. PMC: 7707610. DOI: 10.1371/journal.pone.0242867. View

5.
Posselt G, Schwarz H, Duschl A, Horejs-Hoeck J . Suppressor of cytokine signaling 2 is a feedback inhibitor of TLR-induced activation in human monocyte-derived dendritic cells. J Immunol. 2011; 187(6):2875-84. DOI: 10.4049/jimmunol.1003348. View